APD811 (ralinepag), a novel non-prostanoid IP receptor agonist, has potent antiproliferative and vasorelaxant properties in human pulmonary artery

Linghong Shen(Nanjing Forestry University), Lucie H. Clapp(The London College), Xavier Norel(Inserm), Jitesh A. Patel, Dominic P. Behan, John Adams

UCL Discovery (University College London)

August 1, 2017

Cited by 0

Related Papers

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors

|British Journal of Pharmacology|2021|488

The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors

|British Journal of Pharmacology|2023|390

Terlipressin for norepinephrine-resistant septic shock

|The Lancet|2002|259

Vasopressin: Mechanisms of action on the vasculature in health and in septic shock

|Critical Care Medicine|2006|246

Differential Effects of Stable Prostacyclin Analogs on Smooth Muscle Proliferation and Cyclic AMP Generation in Human Pulmonary Artery

|American Journal of Respiratory Cell and Molecular Biology|2002|232